The novel therapy of this peptide represents a exciting advance in the management of the condition. Distinct from existing drugs, tirzepatide affects dual pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide075165.techionblog.com/42320314/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment